We are live on ! Find out more
CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in COSCIENS Biopharma Inc. Common Stock in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.12% less ownership

Funds ownership: 0.12% → 0% (-0.12%)

100% less funds holding

Funds holding: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $10.3K → $0 (-$10.3K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TWC
TD Waterhouse Canada
Ontario, Canada
-$10.2K
2
Osaic Holdings
Osaic Holdings
Arizona
-$153
Name Holding Trade Value Shares
Change 		Change in
Stake
TWC
1
TD Waterhouse Canada
Ontario, Canada
– -$10.2K -3,860 Closed
Osaic Holdings
2
Osaic Holdings
Arizona
– -$153 -50 Closed

CSCI Hedge Fund Activity: Q4 2025 in Review

0 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q4 2025, worth a combined $0 — down 100% from $10.3K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CSCI and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was TD Waterhouse Canada, exiting entirely with an estimated $10.2K sold.

  • 0 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q4 2025, down from 2 in Q3 2025.
  • Funds reported $0 of COSCIENS Biopharma Inc. Common Stock stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q4 2025 and 2 closed out, a net change of -2 holders.
  • The largest COSCIENS Biopharma Inc. Common Stock seller in Q4 2025 was TD Waterhouse Canada, an estimated $10.2K sold.

Based on aggregated 13F filings for Q4 2025.